SCHEMBL688170

SCHEMBL688170

Cc1ccc([C@H](CC(=O)O)NC(=O)Nc2c(O)c(C)cn(Cc3ccccc3Cl)c2=O)cc1C

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PTGER3 P43115 11/20 0.41
CNR2 P34972 1/20 0.40
SLC22A12 Q96S37 1/20 0.40
CYP26A1 O43174 1/20 0.38
ITGB1 P05556 3/20 0.36
ITGA4 P13612 3/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL688053 0.92 PTGER3 (0.43) PTGER3CNR2SLC22A12TP53MAPT
SCHEMBL686846 0.92 PTGER3 (0.41) PTGER3CNR2SLC22A12CYP26A1ITGB1
SCHEMBL688442 0.92 PTGER3 (0.42) PTGER3CNR2SLC22A12CYP26A1TP53
SCHEMBL29371834 0.91 PTGER3 (0.44) PTGER3CNR2SLC22A12
SCHEMBL688284 0.91 PTGER3 (0.43) PTGER3CNR2SLC22A12CYP26A1ITGB1
SCHEMBL686896 0.91 PTGER3 (0.44) PTGER3CNR2SLC22A12
SCHEMBL688233 0.91 PTGER3 (0.43) PTGER3CNR2SLC22A12CYP26A1TP53
SCHEMBL688343 0.91 PTGER3 (0.43) PTGER3CNR2SLC22A12TP53MAPT
SCHEMBL687923 0.91 PTGER3 (0.41) PTGER3CNR2SLC22A12ITGB1ITGA4
SCHEMBL687045 0.89 PTGER3 (0.42) PTGER3CNR2SLC22A12CYP26A1ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed